2009
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Abstract: SUMMARY MicroRNAs are well-suited to regulate tumor metastasis due to their capacity to coordinately repress numerous target genes, thereby potentially enabling their intervention at multiple steps of the invasion-metastasis cascade. We identify a microRNA exemplifying these attributes, miR-31, whose expression correlates inversely with metastasis in human breast cancer patients. Overexpression of miR-31 in otherwise-aggressive breast tumor cells suppresses metastasis. We deploy a stable microRNA sponge strate…
Search citation statements
Paper Sections
Select...
531
150
126
37
Citation Types
32
691
8
5
Year Published
2009
2025
Publication Types
Select...
684
72
25
4
Relationship
13
772
Authors
Journals
Cited by 785 publications
(736 citation statements)
References 41 publications
32
691
8
5
“…On the other hand, our data differ from those reported by Valastyan et al [56], Creighton et al [57], and Ivanov and colleagues [58], who have observed that miR-31 functions as a tumor suppressor in breast and ovarian carcinomas, as well as malignant pleural mesotheliomas. Discrepancies regarding our findings and those of the latter investigators may be attributable in part to genetic and epigenetic profiles of the various malignancies, reprogramming [59], tissue-specific effects of basal and inducible miR-31 expression, and Wnt signaling [60], [61].…”
Section: Discussioncontrasting
confidence: 99%
“…On the other hand, our data differ from those reported by Valastyan et al [56], Creighton et al [57], and Ivanov and colleagues [58], who have observed that miR-31 functions as a tumor suppressor in breast and ovarian carcinomas, as well as malignant pleural mesotheliomas. Discrepancies regarding our findings and those of the latter investigators may be attributable in part to genetic and epigenetic profiles of the various malignancies, reprogramming [59], tissue-specific effects of basal and inducible miR-31 expression, and Wnt signaling [60], [61].…”
Section: Discussioncontrasting
confidence: 99%
“…Our findings, as well as those of Liu et al [47] are consistent with data demonstrating that up-regulation of miR-31 in oropharyngeal and colorectal carcinomas correlates with advanced stage of disease, and decreased survival of patients with these malignancies [45] , [48] . On the other hand, our data differ from those reported by Valastyan et al [56] , Creighton et al [57] , and Ivanov and colleagues [58] , who have observed that miR-31 functions as a tumor suppressor in breast and ovarian carcinomas, as well as malignant pleural mesotheliomas. Discrepancies regarding our findings and those of the latter investigators may be attributable in part to genetic and epigenetic profiles of the various malignancies, reprogramming [59] , tissue-specific effects of basal and inducible miR-31 expression, and Wnt signaling [60] , [61] .…”
Section: Discussioncontrasting
confidence: 99%
“…In order to do so, we orthotopically implanted into the mammary fat pads of mice 231 cells expressing either shRNAs against the mRNAs encoding these three factors or, alternatively, a miR-31 expression vector. Consistent with our prior findings (6, 7), miR-31 enhanced primary mammary tumor growth by 1.5-fold; in contrast, the combined shRNA-evoked suppression of ITGA5, RDX, and RhoA failed to affect primary tumor size (Fig. 2A).…”
Section: Resultssupporting
confidence: 92%
“…Among these, miR-9, miR-31, miR-34 family and miR-224 have been previously reported to be deregulated in human cancers (29-32). Interestingly, we found that miR-31was up-regulated in N1+ patients in our study cohort (Figure 1A) consistent with miR-31 previously reported to be up-regulated in metastatic colon cancer (33) but contrary to the reported high expression of miR-31 associated with reduced frequency of metastases in breast cancer (34). …”
Section: Resultssupporting
confidence: 91%
